Stenotrophomonas maltophilia endogenous endophthalmitis: clinical presentation, sensitivity spectrum and management

References

1. Al-Jasser A. M. 2006; Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem. Ann Clin Microbiol Antimicrob 5:23 [CrossRef]
   [Google Scholar]
2. Benian O., Alimgil L., Erda N. 2002; Two cases of Stenotrophomonas maltophilia endophthalmitis. Ophthalmic Surg Lasers 33:253–256
   [Google Scholar]
3. Crossman L. C., Gould V. C., Dow J. M., Vernikos G. S., Okazaki A., Sebaihia M., Saunders D., Arrowsmith C., Carver T. other authors 2008; The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9:R74 [CrossRef]
   [Google Scholar]
4. Denton M., Kerr K. G. 1998; Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia . Clin Microbiol Rev 11:57–80
   [Google Scholar]
5. Felegie T. P., Yu V. L., Rumans L. W., Yee R. B. 1979; Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Antimicrob Agents Chemother 16:833–837 [CrossRef]
   [Google Scholar]
6. Jackson T. L., Eykyn S. J., Graham E. M., Stanford M. R. 2003; Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 48:403–423 [CrossRef]
   [Google Scholar]
7. Palleroni N. J., Bradbury J. F. 1993; Stenotrophomonas , a new bacterial genus for Xanthomonas maltophilia . Int J Syst Bacteriol 43:606–609 [CrossRef]
   [Google Scholar]
8. Penland R. L., Wilhelmus K. R. 1996; Stenotrophomonas maltophilia ocular infections. Arch Ophthalmol 114:433–436 [CrossRef]
   [Google Scholar]
9. Swings J., De Vos P., Van den Mooter M., De Ley J. 1983; Transfer of Pseudomonas maltophilia Hugh 1981 to the genus Xanthomonas as Xanthomonas maltophilia (Hugh 1981). comb nov. Int J Syst Bacteriol 33:409–413 [CrossRef]
   [Google Scholar]